CNS & Neurological Disorders - Drug Targets

(Formerly Current Drug Targets - CNS & Neurological Disorders)


Cesar V. Borlongan
Department of Neurosurgery and Brain Repair
University of South Florida Morsani College of Medicine
Tampa, FL


Become EABM
Become Reviewer

Editorial [Hot Topic:Depression (Part 1) (Guest Editors: John H. Kehne and Ronald S. Duman)] promotion: free to download

Volume:6   Issue: 2
Pp: 85-86
Ronald S. Duman and John H. Kehne
DOI: 10.2174/187152707780363249

Metabotropic Glutamate Receptors in the Control of Mood Disorders

Volume:6   Issue: 2
Pp: 87-100
Jeffrey M. Witkin, Gerard J. Marek, Bryan G. Johnson and Darryle D. Schoepp
DOI: 10.2174/187152707780363302

The NMDA Receptor as a Therapeutic Target in Major Depressive Disorder

Volume:6   Issue: 2
Pp: 101-115
Christopher Pittenger, Gerard Sanacora and John H. Krystal
DOI: 10.2174/187152707780363267

AMPA Receptors in the Therapeutic Management of Depression

Volume:6   Issue: 2
Pp: 117-126
D. Bleakman, A. Alt and J. M. Witkin
DOI: 10.2174/187152707780363258

Triple Reuptake Inhibitors (“Broad Spectrum” Antidepressants)

Volume:6   Issue: 2
Pp: 141-149
Phil Skolnick and Anthony S. Basile
DOI: 10.2174/187152707780363285

Targeting Neurotrophic/Growth Factor Expression and Signaling for Antidepressant Drug Development

Volume:6   Issue: 2
Pp: 151-160
Keith Q. Tanis, Samuel S. Newton and Ronald S. Duman
DOI: 10.2174/187152707780363276